https://doctransparency.com/doctor/fl/naples/joseph-pergolizzi-1922198068
Not Medicare Enrolled

Dr. Joseph Pergolizzi, M.D.

Anesthesiology · Naples, FL
Speaking/Promotional
868 106TH AVE N, Naples, FL 34108
2395973564
In practice since 2006 (19 years)
NPI: 1922198068 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pergolizzi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pergolizzi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pergolizzi

Dr. Joseph Pergolizzi is an anesthesiology in Naples, FL, with 19 years in practice.

Between the years covered by Open Payments, Dr. Pergolizzi received a total of $730,899 from 30 pharmaceutical and/or device companies across 615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pergolizzi is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $730,899 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$730,899
Total received (2018-2024)
Avg $104,414/year across 7 years
Top 0% in FL for anesthesiology
30
Companies
615
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$493,991 (67.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$231,939 (31.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,969 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$72,950
2023
$24,387
2022
$18,787
2021
$10,868
2020
$28,268
2019
$146,214
2018
$429,425

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$183,930
BioDelivery Sciences International, Inc.
$162,800
INSYS Therapeutics Inc
$81,155
Daiichi Sankyo Inc.
$66,607
US WorldMeds, LLC
$50,403
Bausch Health US, LLC
$40,460
Scilex Pharmaceuticals Inc.
$40,455
SCILEX PHARMACEUTICALS INC.
$17,055
Ortho Dermatologics, a division of Bausch Health US, LLC
$14,711
Janssen Research & Development, LLC
$9,014
AstraZeneca Pharmaceuticals LP
$8,877
Mallinckrodt LLC
$7,841
Bayer Healthcare LLC
$5,750
Takeda Pharmaceuticals U.S.A., Inc.
$5,250
Heron Therapeutics, Inc.
$4,649
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$4,272
Sentynl Therapeutics, Inc.
$4,264
Par Pharmaceutical, Inc.
$4,264
Regeneron Pharmaceuticals, Inc.
$3,975
Tris Pharma Inc
$3,802
Lilly USA, LLC
$3,600
Kowa Pharmaceuticals America, Inc.
$2,500
Angelini Pharma Inc.
$2,500
ACADIA Pharmaceuticals Inc
$2,138
Collegium Pharmaceutical, Inc.
$253
GRT US Holding, Inc.
$194
Averitas Pharma Inc.
$90
Hikma Pharmaceuticals USA
$42
Eli Lilly and Company
$32
Shionogi Inc
$16
Top 3 companies account for 58.5% of total payments
Associated products mentioned in payments ›
APLENZIN · Abstral · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Belbuca · CINVANTI · Dyanavel XR · LUCEMYRA · Lucemyra/Lofexidine · MOVANTIK · MYOBLOC · Morphabond ER · Movantik · QUTENZA · Qutenza · RELISTOR · RoxyBond · Seglentis · XTAMPZA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in anesthesiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for anesthesiology in FL.

Looking for a anesthesiology in Naples?
Compare anesthesiologys in the Naples area by procedure volume, costs, and industry payment transparency.
Browse anesthesiologys nearby

Geographic Context

Anesthesiologys within 10 mi
63
Per 100K population
16.3
County median income
$86,173
Nearest hospital
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
5.8 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment— Not enrolledN/A
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pergolizzi is a anesthesiology, and high industry engagement (speaking/promotional, top 0%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Pergolizzi receive payments from pharmaceutical companies?
Yes. Dr. Pergolizzi received a total of $730,899 from 30 companies across 615 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Pergolizzi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →